[{"address1": "4224 Campus Point Court", "address2": "Suite 210", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 202 6300", "website": "https://www.regulusrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Regulus Therapeutics Inc. engages in the development of drugs designed to inhibit dysregulated microRNA targets for the benefit of patients with genetically based orphan diseases. The company develops farabursen, an anti-miR oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease. It is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was formerly known as Regulus Therapeutics LLC and changed its name to Regulus Therapeutics Inc. in January 2009. The company was incorporated in 2007 and is based in San Diego, California. As of June 25, 2025, Regulus Therapeutics Inc. operates as a subsidiary of Novartis AG.", "fullTimeEmployees": 34, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joseph P. Hagan M.B.A.", "age": 55, "title": "CEO & Director", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 1063084, "exercisedValue": 0, "unexercisedValue": 117019}, {"maxAge": 1, "name": "Dr. Preston S. Klassen M.D., M.H.S.", "age": 55, "title": "President, Head of Research & Development and Director", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 760760, "exercisedValue": 0, "unexercisedValue": 39950}, {"maxAge": 1, "name": "Ms. Crispina  Calsada CPA", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 669100, "exercisedValue": 0, "unexercisedValue": 35109}, {"maxAge": 1, "name": "Mr. Daniel J. Penksa", "age": 38, "title": "VP of Finance & Controller", "yearBorn": 1986, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher Ray Aker J.D.", "age": 63, "title": "Senior VP, General Counsel & Corporate Secretary", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 575942, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Claire Susan Padgett M.S., M.T., Ph.D.", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rekha  Garg M.D., M.S.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Edmund  Lee Ph.D.", "title": "Vice President of Translational Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 3, "compensationRisk": 9, "shareHolderRightsRisk": 6, "overallRisk": 7, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.16, "open": 8.15, "dayLow": 8.16, "dayHigh": 8.16, "regularMarketPreviousClose": 8.16, "regularMarketOpen": 8.15, "regularMarketDayLow": 8.16, "regularMarketDayHigh": 8.16, "payoutRatio": 0.0, "beta": 0.368, "forwardPE": -6.743801, "volume": 8756394, "regularMarketVolume": 8756394, "averageVolume": 2226204, "averageVolume10days": 4003012, "averageDailyVolume10Day": 4003012, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 564950208, "fiftyTwoWeekLow": 0.8301, "fiftyTwoWeekHigh": 8.345, "fiftyDayAverage": 7.1432, "twoHundredDayAverage": 2.890775, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 500988160, "profitMargins": 0.0, "floatShares": 57670611, "sharesOutstanding": 69234096, "sharesShort": 1758628, "sharesShortPriorMonth": 1909830, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.0254, "heldPercentInsiders": 0.02707, "heldPercentInstitutions": 0.82874, "shortRatio": 1.57, "shortPercentOfFloat": 0.0323, "impliedSharesOutstanding": 69234096, "bookValue": 1.041, "priceToBook": 7.8386164, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -47523000, "trailingEps": -0.68, "forwardEps": -1.21, "lastSplitFactor": "1:10", "lastSplitDate": 1656460800, "enterpriseToEbitda": -9.747, "52WeekChange": 3.6363635, "SandP52WeekChange": 0.12677538, "quoteType": "EQUITY", "currentPrice": 8.16, "targetHighPrice": 7.0, "targetLowPrice": 7.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 65368000, "totalCashPerShare": 0.944, "ebitda": -51401000, "totalDebt": 1401000, "quickRatio": 14.866, "currentRatio": 16.305, "debtToEquity": 2.03, "returnOnAssets": -0.34234002, "returnOnEquity": -0.53815, "grossProfits": -36146000, "freeCashflow": -25612750, "operatingCashflow": -43544000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "RGLS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1349357400000, "regularMarketChangePercent": 0.0, "regularMarketPrice": 8.16, "regularMarketChange": 0.0, "regularMarketDayRange": "8.16 - 8.16", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2226204, "fiftyTwoWeekLowChange": 7.3299, "fiftyTwoWeekLowChangePercent": 8.830141, "fiftyTwoWeekRange": "0.8301 - 8.345", "fiftyTwoWeekHighChange": -0.18500042, "fiftyTwoWeekHighChangePercent": -0.022169013, "fiftyTwoWeekChangePercent": 363.63635, "dividendDate": 1538611200, "earningsTimestamp": 1746734703, "earningsTimestampStart": 1754596800, "earningsTimestampEnd": 1754596800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.68, "epsForward": -1.21, "epsCurrentYear": -1.14, "priceEpsCurrentYear": -7.1578946, "fiftyDayAverageChange": 1.0167999, "fiftyDayAverageChangePercent": 0.14234516, "twoHundredDayAverageChange": 5.269225, "twoHundredDayAverageChangePercent": 1.8227725, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "delistingDate": "2025-07-04", "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "shortName": "Regulus Therapeutics Inc.", "longName": "Regulus Therapeutics Inc.", "corporateActions": [], "regularMarketTime": 1750795201, "exchange": "NCM", "messageBoardId": "finmb_36742485", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Regulus Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-07-05"}]